Monogram Biosciences stock: Panic selling after news of delayed Pfizer HIV drug

Tag(s): FDA
Add to My Group

June 21, 2007 at 11:48:05

by Peter Rost Page 1 of 1 page(s)

http://www.robkall.com

Perhaps the initial panic selling of Monogram Biosciences stock this morning shouldn't be surprising. Monogram manufactures a diagnostic test used to identify HIV patients who would respond to Pfizer's maraviroc drug, which didn't get the expected FDA approval on June 20.

Peter Rost, M.D., is a former Vice President of Pfizer. He is the author of "The Whistleblower, Confessions of a Healthcare Hitman." He also writes the daily Dr. Peter Rost blog.

Contact Author

Contact Editor

View Other Articles by Author

Bookmark this page: (what's this?)

(More...)

No comments

Tags for This Article:

Populum Tag Cloud
Control Panel
Fine tune your search to access content

All	Articles
Diaries	QuickLinks

All time Last 6 mos Last month Last week Last 24 hrs	From: Month Day Year To: Month Day Year
Alphabet Popularity	Count ON Count OFF
This Level	Also Sub-levels

Copyright © OpEdNews, 2002-2007